Hypopigmented burn hypertrophic scar contains melanocytes that can be signaled to re-pigment by synthetic alpha-melanocyte stimulating hormone in vitro.

MedStar author(s):
Citation: PLoS ONE [Electronic Resource]. 16(3):e0248985, 2021.PMID: 33765043Institution: MedStar Health Research Institute | MedStar Washington Hospital CenterDepartment: Firefighters' Burn and Surgical Research Laboratory | Surgery/Burn ServicesForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *alpha-MSH/me [Metabolism] | *Burns/pa [Pathology] | *Cicatrix, Hypertrophic/pa [Pathology] | *Hypopigmentation/pa [Pathology] | *Melanocytes/pa [Pathology] | Adult | Animals | Biopsy | Biosynthetic Pathways | Burns/co [Complications] | Burns/ge [Genetics] | Cells, Cultured | Cicatrix, Hypertrophic/co [Complications] | Cicatrix, Hypertrophic/ge [Genetics] | Humans | Hyperpigmentation/co [Complications] | Hyperpigmentation/pa [Pathology] | Hypopigmentation/co [Complications] | Hypopigmentation/ge [Genetics] | Male | Melanins/bi [Biosynthesis] | Melanocytes/me [Metabolism] | Middle Aged | Phenotype | Pigmentation | Swine | Up-Regulation/ge [Genetics] | Young AdultYear: 2021ISSN:
  • 1932-6203
Name of journal: PloS oneAbstract: There are limited treatments for dyschromia in burn hypertrophic scars (HTSs). Initial work in Duroc pig models showed that regions of scar that are light or dark have equal numbers of melanocytes. This study aims to confirm melanocyte presence in regions of hypo- and hyper-pigmentation in an animal model and patient samples. In a Duroc pig model, melanocyte presence was confirmed using en face staining. Patients with dyschromic HTSs had demographic, injury details, and melanin indices collected. Punch biopsies were taken of regions of hyper-, hypo-, or normally pigmented scar and skin. Biopsies were processed to obtain epidermal sheets (ESs). A subset of ESs were en face stained with melanocyte marker, S100beta. Melanocytes were isolated from a different subset. Melanocytes were treated with NDP alpha-MSH, a pigmentation stimulator. mRNA was isolated from cells, and was used to evaluate gene expression of melanin-synthetic genes. In patient and pig scars, regions of hyper-, hypo-, and normal pigmentation had significantly different melanin indices. S100beta en face staining showed that regions of hyper- and hypo-pigmentation contained the same number of melanocytes, but these cells had different dendricity/activity. Treatment of hypo-pigmented melanocytes with NDP alpha-MSH produced melanin by microscopy. Melanin-synthetic genes were upregulated in treated cells over controls. While traditionally it may be thought that hypopigmented regions of burn HTS display this phenotype because of the absence of pigment-producing cells, these data show that inactive melanocytes are present in these scar regions. By treating with a pigment stimulator, cells can be induced to re-pigment.All authors: Carney BC, Johnson LS, McLawhorn MM, Moffatt LT, Rosenthal DS, Shupp JW, Simbulan-Rosenthal CM, Travis TEOriginally published: PLoS ONE [Electronic Resource]. 16(3):e0248985, 2021.Fiscal year: FY2021Digital Object Identifier: ORCID: Date added to catalog: 2021-06-07
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33765043 Available 33765043

There are limited treatments for dyschromia in burn hypertrophic scars (HTSs). Initial work in Duroc pig models showed that regions of scar that are light or dark have equal numbers of melanocytes. This study aims to confirm melanocyte presence in regions of hypo- and hyper-pigmentation in an animal model and patient samples. In a Duroc pig model, melanocyte presence was confirmed using en face staining. Patients with dyschromic HTSs had demographic, injury details, and melanin indices collected. Punch biopsies were taken of regions of hyper-, hypo-, or normally pigmented scar and skin. Biopsies were processed to obtain epidermal sheets (ESs). A subset of ESs were en face stained with melanocyte marker, S100beta. Melanocytes were isolated from a different subset. Melanocytes were treated with NDP alpha-MSH, a pigmentation stimulator. mRNA was isolated from cells, and was used to evaluate gene expression of melanin-synthetic genes. In patient and pig scars, regions of hyper-, hypo-, and normal pigmentation had significantly different melanin indices. S100beta en face staining showed that regions of hyper- and hypo-pigmentation contained the same number of melanocytes, but these cells had different dendricity/activity. Treatment of hypo-pigmented melanocytes with NDP alpha-MSH produced melanin by microscopy. Melanin-synthetic genes were upregulated in treated cells over controls. While traditionally it may be thought that hypopigmented regions of burn HTS display this phenotype because of the absence of pigment-producing cells, these data show that inactive melanocytes are present in these scar regions. By treating with a pigment stimulator, cells can be induced to re-pigment.

English

Powered by Koha